SCHEMBL8093740

SCHEMBL8093740

COc1ccc(COc2nc(-c3ccc(F)cc3)c(-c3ccc(S(N)(=O)=O)cc3)cc2C#N)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 13/20 0.60
CA12 O43570 3/20 0.48
CA2 P00918 3/20 0.48
CA1 P00915 2/20 0.48
CA7 P43166 2/20 0.48
CA9 Q16790 2/20 0.48
CNR2 P34972 1/20 0.45
MAOA P21397 1/20 0.44
CA4 P22748 1/20 0.44
MAOB P27338 1/20 0.44
CA5A P35218 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
SQOR Q9Y6N5 1/20 0.43
PTGS2 P35354 2/20 0.42
PTGS1 P23219 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8086461 0.94 CNR1 (0.61) CNR1CA12CA2CA1CA7
SCHEMBL8101056 0.92 CNR1 (0.61) CNR1CNR2SQORPTGS2PTGS1
SCHEMBL8776765 0.91 CNR1 (0.60) CNR1CNR2SQORPTGS2PTGS1
SCHEMBL8095797 0.89 CNR1 (0.69) CNR1CA12CA2CA1CA7
SCHEMBL8093875 0.89 CNR1 (0.64) CNR1CA12CA2CA1CA7
SCHEMBL8095103 0.86 CNR1 (0.61) CNR1CNR2PTGS2PTGS1
SCHEMBL8093195 0.86 PTGS2 (0.47) CNR1CA12CA2CA1CA9
SCHEMBL8094551 0.85 CNR1 (0.49) CNR1CA12CA2CA1CA9
SCHEMBL8087526 0.85 CNR1 (0.51) CNR1CA12CA2CA1CA7
SCHEMBL8094547 0.84 PTGS2 (0.60) CNR1CA12CA2CA1CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP claimed
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP claimed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO claimed
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP disclosed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO disclosed